In this video

Share

GlaxoSmithKline China charges update

CNBC's Eunice Yoon discusses the damage control coming out of GlaxoSmithKline, which says the charges out of China were disappointing and the company is commissioning its own review.
02:14
Wed, Jul 24 20137:47 AM EDT